Sun.Feb 09, 2025

article thumbnail

Brain Bleed Survivors Walk a Razor-Thin Line Taking DOACs

Med Page Today

(MedPage Today) -- LOS ANGELES -- In the PRESTIGE-AF trial, survivors of intracerebral hemorrhage (ICH) had good protection against future ischemic events using direct oral anticoagulants (DOACs) -- though, as feared, bleeding side effects.

article thumbnail

The HCPFive: Top News for Healthcare Providers from the Week of 02/02

HCPLive

Our top 5 headlines include a trial of gene-edited pig kidneys, a first-of-its-kind antibiotic approval, and new guidelines for migraine.

64
article thumbnail

Major Adverse Cardiovascular Events 1 Year After Discharge in Out-of-Hospital Cardiac Arrest Survivors

Circulation

Circulation, Volume 151, Issue 6 , Page 421-423, February 11, 2025.

article thumbnail

Secondary Prevention Medications for CVD Underutilized in Global Analysis

HCPLive

Use of medications for secondary CVD prevention is low globally, and in most country income-level groups, with no indication of improvement.

59
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

article thumbnail

Remuscularizing the failing heart in primates

Nature Reviews - Cardiology

Nature Reviews Cardiology, Published online: 10 February 2025; doi:10.1038/s41569-025-01136-z Tissue engineered heart muscle implanted on to the epicardium can structurally and functionally remuscularize the failing hearts of rhesus macaques, with no major adverse effects; a clinical trial of this approach is now underway in patients with heart failure.

article thumbnail

DECT Scans Unable to Detect Gout Nephropathy

HCPLive

Dual-energy computed tomography is able to characterize MSU in joints as well as chronic asymptomatic urolithiasis in kidneys.

52

More Trending

article thumbnail

Cox Regression Model in Clinical Research: Overview of Key Properties and Interpretation

Circulation

Circulation, Volume 151, Issue 6 , Page 337-339, February 11, 2025.

article thumbnail

Which common medicine won a place in the Guinness Book of World Records?

Heart Sisters

It’s been in use for thousands of years.

article thumbnail

Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects

Circulation

Circulation, Volume 151, Issue 6 , Page 400-415, February 11, 2025. Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk factor for astherosclerotic cardiovascular disease, with proinflammatory and prothrombotic mechanisms contributing to its atherogenicity.

article thumbnail

Peripheral Venous Pressure-Guided Decongestion: A New Approach Yet to Prove Beneficial

The American Journal of Cardiology

Publication date: Available online 8 February 2025 Source: The American Journal of Cardiology Author(s): Timir K Paul

40
article thumbnail

Antagonizing HFpEF by Targeting Fibrosis

Circulation

Circulation, Volume 151, Issue 6 , Page 396-399, February 11, 2025.

article thumbnail

From the Literature

Circulation

Circulation, Volume 151, Issue 6 , Page 416-417, February 11, 2025.

article thumbnail

Response by Shen et al to Letter Regarding Article, “Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF”

Circulation

Circulation, Volume 151, Issue 6 , Page e38-e38, February 11, 2025.

article thumbnail

Letter by Tunçez and Gürses Regarding Article, “Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF”

Circulation

Circulation, Volume 151, Issue 6 , Page e37-e37, February 11, 2025.